Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP767076.RAwfeYlJbLka7FnwI2-TLigN1-zY8cikgNGh741lRTQWo130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767076.RAwfeYlJbLka7FnwI2-TLigN1-zY8cikgNGh741lRTQWo130_provenance.
• NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_provenance.
• assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP580638.RAa4jDlamrltq7oo_JyJ91xqSNJgAffICkezUON_XGyYE130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580638.RAa4jDlamrltq7oo_JyJ91xqSNJgAffICkezUON_XGyYE130_provenance.
• NP379397.RA9Ue33zcbowFJszglJpPFy9kCRKImHVze4KF_UOuLEnM130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379397.RA9Ue33zcbowFJszglJpPFy9kCRKImHVze4KF_UOuLEnM130_provenance.
• NP955841.RAF9ZafN-OUZ09NJGiUhmdHQhEY3un6nXiElSSMhTx3SM130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955841.RAF9ZafN-OUZ09NJGiUhmdHQhEY3un6nXiElSSMhTx3SM130_provenance.
• NP955849.RAIS-RZ7Z9iJ6DITXHKKOInYlk9CeDLd2zDKuFoL5kGFc130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955849.RAIS-RZ7Z9iJ6DITXHKKOInYlk9CeDLd2zDKuFoL5kGFc130_provenance.
• NP580639.RAPuPb80Z44xSkUU6AoMMEXBxIFa8DKNtKHCsU5YThWyg130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580639.RAPuPb80Z44xSkUU6AoMMEXBxIFa8DKNtKHCsU5YThWyg130_provenance.
• NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_provenance.
• NP580640.RAwvl07-gwaXsnkGA1RT2duBTP5gZNUBbarlrD9FL5HmU130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580640.RAwvl07-gwaXsnkGA1RT2duBTP5gZNUBbarlrD9FL5HmU130_provenance.